Nitric oxide and DOPAC (cas 102-32-9)-induced cell death: From GSH depletion to mitochondrial energy crisis
-
Add time:08/07/2019 Source:sciencedirect.com
The molecular mechanisms inherent to cell death associated with Parkinson's disease are not clearly understood. Diverse pathways, sequence of events and models have been explored in several studies. Recently, we have proposed an integrative mechanism, encompassing the interaction of nitric oxide (NO) and a major dopamine metabolite, dihydroxyphenylacetic (DOPAC), leading to a synergistic mitochondrial dysfunction and cell death that may be operative in PD. In this study, we have studied the sequence of events underlying the mechanisms of cell death in PC12 cells exposed to NO and DOPAC in terms of: a) free radical production; b) modulation by glutathione (GSH); c) energetic status and d) outer membrane mitochondria permeability. Using Electron Paramagnetic Resonance (EPR) it is shown the early production of oxygen free radicals followed by a depletion of GSH reflected by an increase of GSSG/GSH ratio in the cells treated with the mixture of NO/DOPAC, as compared with the cells individually exposed to each of the stimulus. Glutathione ethyl ester (GSH-EE) and N-acetylcysteine (NAC) may rescue cells from death, increasing GSH content and preventing ATP loss in cells treated with the mixture DOPAC/NO but failed to exert similar effects in the cells challenged only with NO. The depletion of GSH is accompanied by a decreased activity of mitochondrial complex I. At a later stage, the concerted action of DOPAC and NO include a rise in the ratio Bax/Bcl-2, an observation not evident when cells were exposed only to NO. The results support a free radical-induced pathway leading to cell death involving the concerted action of DOPAC and NO and the critical role of GSH in maintaining a functional mitochondria.
We also recommend Trading Suppliers and Manufacturers of DOPAC (cas 102-32-9). Pls Click Website Link as below: cas 102-32-9 suppliers
Prev:At Low Concentrations, 3,4-Dihydroxyphenylacetic Acid (DOPAC (cas 102-32-9)) Binds Non-Covalently to α-Synuclein and Prevents Its Fibrillation
Next:Maternal undernutrition during lactation alters nicotine reward and DOPAC (cas 102-32-9)/dopamine ratio in cerebral cortex in adolescent mice, but does not affect nicotine-induced nAChRs upregulation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Ascorbate reduces morphine-induced extracellular DOPAC (cas 102-32-9) level in the nucleus accumbens: A microdialysis study in rats08/10/2019
- 3,4-Dihydroxyphenylacetic acid (DOPAC (cas 102-32-9)) modulates the toxicity induced by nitric oxide in PC-12 cells via mitochondrial dysfunctioning08/09/2019
- Maternal undernutrition during lactation alters nicotine reward and DOPAC (cas 102-32-9)/dopamine ratio in cerebral cortex in adolescent mice, but does not affect nicotine-induced nAChRs upregulation08/08/2019
- At Low Concentrations, 3,4-Dihydroxyphenylacetic Acid (DOPAC (cas 102-32-9)) Binds Non-Covalently to α-Synuclein and Prevents Its Fibrillation08/06/2019
- New fluorescent receptor composed of two imidazoliums, two pyrenes and a boronic acid for the recognition of DOPAC (cas 102-32-9)08/05/2019
- Experimental and theoretical studies of electrochemical characteristics of 3,4-dihydroxyphenylacetic acid (DOPAC (cas 102-32-9))08/04/2019
- Conformational preferences of 3,4-dihydroxyphenylacetic acid (DOPAC (cas 102-32-9))08/03/2019


